COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 2568: Articles 25671-25680  | Next

Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets
Reps, J. M., Kim, C., Williams, R. D., Markus, A. F., Yang, C., Salles, T. D., Falconer, T., Jonnagaddala, J., Williams, A., Fernandez-Bertolin, S., DuVall, S. L., Kostka, K., Rao, G., Shoaibi, A., Ostropolets, A., Spotnitz, M. E., Zhang, L., Casajust, P., Steyerberg, E., Nyberg, F., Kaas-Hansen, B. S., Choi, Y. H., Morales, D., Liaw, S.-T., Abrahao, M. T. F., Areia, C., Matheny, M. E., Aragon, M., Park, R. W., Hripcsak, G., Reich, C. G., Suchard, M. A., You, S. C., Ryan, P. B., Prieto-Alhambra, D., Rijnbeek, P. R.
10.1101/2020.06.15.20130328 — Posted: 2020-06-17
in-silica Analysis of SARS-CoV-2 viral strain using Reverse Vaccinology Approach: A Case Study for USA
Agarwal, A.
10.1101/2020.06.16.154559 — Posted: 2020-06-17
Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp
Eskier, D., Suner, A., Karakulah, G., Oktay, Y.
10.1101/2020.06.15.153239 — Posted: 2020-06-17
Virus survival in evaporated saliva microdroplets deposited on inanimate surfaces
Fedorenko, A., Grinberg, M., Orevi, T., Kashtan, N.
10.1101/2020.06.15.152983 — Posted: 2020-06-16
Comparing library preparation methods for SARS-CoV-2 multiplex amplicon sequencing on the Illumina MiSeq platform
Batty, E. M., Kochakarn, T., Wangwiwatsin, A., Joonlasak, K., Huang, A. T., Panthan, B., Jiaranai, P., Kümpornsin, K., Kotanan, N., Manasatienkij, W., Watthanachockchai, T., Rakmanee, K., Jones, A. R., Fernandez, S., Sensorn, I., Sungkanuparph, S., Pasomsub, E., Klungthong, C., Chookajorn, T., Chantratita, W.
10.1101/2020.06.16.154286 — Posted: 2020-06-16
Genomic modeling as an approach to identify surrogates for use in experimental validation of SARS-CoV-2 and HuNoVs inactivation by UV-C treatment
Pendyala, B., Patras, A., DSouza, D.
10.1101/2020.06.14.151290 — Posted: 2020-06-16
Machine Learning Models Identify Inhibitors of SARS-CoV-2
Gawriljuk, V. O., Kyaw Zin, P. P., Foil, D. H., Bernatchez, J., Beck, S., Beutler, N., Ricketts, J., Yang, L., Rogers, T., Puhl, A. C., Zorn, K. M., Lane, T. R., Godoy, A. S., Olivia, G., Siqueira-Neto, J. L., Madrid, P., Ekins, S.
10.1101/2020.06.16.154765 — Posted: 2020-06-16
Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
de Almeida, R. M. C., Thomas, G. L., Glazier, J. A.
10.1101/2020.06.16.155267 — Posted: 2020-06-16
Antigenic evolution on global scale reveals potential natural selection of SARS-CoV-2 by pre-existing cross-reactive T cell immunity
Zhang, C., Jin, X., Chen, X., Leng, Q., Qiu, T.
10.1101/2020.06.16.154591 — Posted: 2020-06-16
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
Hanson, Q. M., Wilson, K. M., Shen, M., Itkin, Z., Eastman, R. T., Shinn, P., Hall, M. D.
10.1101/2020.06.16.154708 — Posted: 2020-06-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).